HK1151242A1 - 肽組合物及使用方法 - Google Patents

肽組合物及使用方法

Info

Publication number
HK1151242A1
HK1151242A1 HK11105411.7A HK11105411A HK1151242A1 HK 1151242 A1 HK1151242 A1 HK 1151242A1 HK 11105411 A HK11105411 A HK 11105411A HK 1151242 A1 HK1151242 A1 HK 1151242A1
Authority
HK
Hong Kong
Prior art keywords
mntf
methods
peptide compositions
compositions
mntf peptide
Prior art date
Application number
HK11105411.7A
Other languages
English (en)
Inventor
‧寇
‧金迪
Original Assignee
健能萬生物製藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健能萬生物製藥公司 filed Critical 健能萬生物製藥公司
Publication of HK1151242A1 publication Critical patent/HK1151242A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
HK11105411.7A 2008-02-21 2011-05-31 肽組合物及使用方法 HK1151242A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6666908P 2008-02-21 2008-02-21
PCT/US2009/034923 WO2009105780A2 (en) 2008-02-21 2009-02-23 Mntf peptide compositions and methods of use

Publications (1)

Publication Number Publication Date
HK1151242A1 true HK1151242A1 (zh) 2012-01-27

Family

ID=40792684

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11105411.7A HK1151242A1 (zh) 2008-02-21 2011-05-31 肽組合物及使用方法

Country Status (10)

Country Link
US (1) US8846615B2 (zh)
EP (1) EP2247300B1 (zh)
JP (1) JP5718649B2 (zh)
CN (1) CN101951942B (zh)
AU (1) AU2009217266B2 (zh)
CA (1) CA2716392C (zh)
DK (1) DK2247300T3 (zh)
ES (1) ES2569552T3 (zh)
HK (1) HK1151242A1 (zh)
WO (1) WO2009105780A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2247300T3 (en) 2008-02-21 2016-05-09 Genervon Biopharmaceuticals Llc Mntf peptide compositions and methods of use thereof
TWI565712B (zh) 2014-10-20 2017-01-11 福又達生物科技股份有限公司 增進神經元生長的胜肽及其應用
WO2016210123A1 (en) 2015-06-26 2016-12-29 Genervon Biopharmaceuticals, LLC Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease
CN111925411B (zh) * 2017-06-29 2022-04-08 安徽省农业科学院农产品加工研究所 一种含有Cys-Ser的高锌螯合活性锌螯合肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69740051D1 (de) * 1996-09-27 2010-12-23 Genervon Biopharmaceuticals Llc Isolierung und verwendung motoneuronotrophischer faktoren
US6309877B1 (en) * 1996-09-27 2001-10-30 Km Biotech, Inc. Polynucleotides encoding motoneuronotrophic factors
US6841531B2 (en) * 1996-09-27 2005-01-11 Genervon Biopharmaceuticals Llc Methods and use of motoneuronotrophic factors
DK1587526T3 (da) * 2003-01-21 2012-02-06 Genervon Biopharmaceuticals Llc MNTF-peptider og sammensætninger og anvendelsesmåder
JP5270362B2 (ja) * 2005-11-10 2013-08-21 ジェナボン バイオファーマシューティカルズ エルエルシー 幹細胞のmntf分化および成長
US20100028916A1 (en) * 2006-06-09 2010-02-04 Bio Pur Ag Method for the detection of enzymatic reactions
WO2008057609A2 (en) * 2006-11-10 2008-05-15 Genervon Biopharmaceuticals Llc Methods of treating neuronal disorders using mntf peptides and analogs thereof
DK2247300T3 (en) 2008-02-21 2016-05-09 Genervon Biopharmaceuticals Llc Mntf peptide compositions and methods of use thereof
EP2247613B1 (en) * 2008-02-21 2018-05-30 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of mntf peptides

Also Published As

Publication number Publication date
AU2009217266B2 (en) 2014-10-16
DK2247300T3 (en) 2016-05-09
JP5718649B2 (ja) 2015-05-13
CA2716392C (en) 2019-05-21
CN101951942A (zh) 2011-01-19
WO2009105780A2 (en) 2009-08-27
EP2247300A2 (en) 2010-11-10
JP2011513239A (ja) 2011-04-28
WO2009105780A3 (en) 2009-11-05
CA2716392A1 (en) 2009-08-27
US8846615B2 (en) 2014-09-30
EP2247300B1 (en) 2016-04-13
US20090286747A1 (en) 2009-11-19
ES2569552T3 (es) 2016-05-11
AU2009217266A1 (en) 2009-08-27
CN101951942B (zh) 2014-09-03

Similar Documents

Publication Publication Date Title
IL245172A0 (en) Pharmaceutical preparations and methods for transferring them related to them
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
IL209136A0 (en) Compositions of peptides and processes of preparation thereof
EP2364161A4 (en) COMPOSITIONS CONTAINING SATIOGENES AND METHODS OF USE
EP2373679A4 (en) HEPPIDINE MINI PEPTIDES AND METHODS OF USE
EP2334185A4 (en) COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
IL208946A0 (en) Immunomodulating compositions and methods of use thereof
PT2320911E (pt) Composições de vasoconstrição e métodos de utilização
HK1144823A1 (zh) 前胰島肽和其類似物的成份和使用方法
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
HRP20181380T1 (hr) Lipopeptidne kompozicije i s njima povezani postupci
EP2403935A4 (en) COMPOSITIONS COMPRISING ANGIOGENIC FACTORS AND METHODS OF USE
EP2506709A4 (en) AMANTADIN COMPOSITIONS AND METHODS OF USE THEREOF
EP2346521A4 (en) PEPTIDES AND METHODS OF USE
EP2376101A4 (en) ARRESTIN EFFECTORS AND COMPOSITIONS AND METHOD OF APPLICATION THEREFOR
HK1151438A1 (zh) 氣體瀉流組合物以及製造和使用其的方法
GB0812890D0 (en) Compositions and methods of making compositions
ZA201102207B (en) Cinnamandehyde-allicin compositions and their method of use
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
HK1151242A1 (zh) 肽組合物及使用方法
ZA201004894B (en) Nuctraceutical composition and methods of use
HK1166953A1 (zh) 組合物及使用方法
ZA201004893B (en) Nuctraceutical composition and methods of use
PL2128112T3 (pl) Cząsteczkowe kompozycje odpowietrzające i sposoby ich stosowania
GB0820804D0 (en) Perinropril composition and method of use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210223